Literature DB >> 2685223

Albumin microspheres. II: Applications in drug delivery.

P K Gupta1, C T Hung.   

Abstract

Albumin microspheres are colloidal particles which are known to sustain the release of entrapped therapeutic agent(s). The rate at which these particles metabolise in vivo can be manoeuvred by varying their synthetic conditions. These particles alter the in vivo distribution of included drugs and hence this carrier has been extensively investigated for drug delivery and targeting in laboratory animals. Attempts have also been made to use this carrier for the delivery of anti-cancer agents in patients with liver cancer. This review is focused on the experimental and clinical applications of albumin microspheres in drug delivery. An account of the toxicological properties of these particles is also presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685223     DOI: 10.3109/02652048909031166

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  4 in total

1.  Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique.

Authors:  B G Müller; H Leuenberger; T Kissel
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

2.  Targeted albumin-based nanoparticles for delivery of amphipathic drugs.

Authors:  Rongzuo Xu; Michael Fisher; R L Juliano
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

3.  Preparation of meglumine antimonate loaded albumin nanoparticles and evaluation of its anti-leishmanial activity: an in vitro assay.

Authors:  Afshin Barazesh; Mohammad Hossein Motazedian; Naghmeh Sattarahmady; Mohammad Hossein Morowvat; Sajad Rashidi
Journal:  J Parasit Dis       Date:  2018-07-09

4.  Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats.

Authors:  Shaimaa S Ibrahim; Rihab Osman; Nahed D Mortada; Ahmed-Shawky Geneidy; Gehanne A S Awad
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.